Navigation Links
Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting

-NS4A Antagonist Demonstrates Clinical Activity, a Novel Mechanism of Action and In Vitro Compatibility with other HCV Inhibitors-

NEW HAVEN, Conn., April 16, 2007 /PRNewswire-FirstCall/ -- Achillion Pharmaceuticals, Inc. today announced the presentation of data validating the clinical antiviral activity of one of Achillion's NS4A antagonists, ACH-806, for the treatment of hepatitis C virus (HCV) infection at the 42nd Annual Meeting of the European Association for the Study of the Liver (EASL). In three separate presentations, Achillion researchers discussed the potent antiviral activity in HCV-infected subjects, synergy with other classes of HCV inhibitors, and the unique mode of action of a NS4A antagonist. Achillion has shown that blocking NS4A, a viral protein that binds to a portion of HCV protease, inhibits HCV replication. This program is part of a collaboration and exclusive license agreement with Gilead Sciences for the research, development and commercialization of compounds for the treatment of chronic HCV.

In a late-breaker session on April 14th at 5:00 PM, John Pottage, M.D., Senior Vice President and Chief Medical Officer at Achillion, discussed clinical data in a presentation titled, "Short-term Antiviral Activity and Safety of ACH-806 (GS-9132), an NS4A Antagonist, in HCV Genotype 1 Infected Individuals." The randomized, double-blind, placebo-controlled dose-escalation trial measured the antiviral activity, safety and pharmacokinetics of 300 mg of ACH-806 or placebo, dosed orally twice daily as a monotherapy over 5 days. The mean change in HCV RNA (log10) at day 5 was a decrease of 0.91 from baseline for treated subjects versus an increase of 0.05 for control subjects. Elevations in serum creatinine (a marker of kidney function) were observed in ACH-806 treated subjects and were reversible after completion of dosing.

"This study provides the first demonstration of human antiviral a
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:9/1/2015)... 1, 2015 Agena Bioscience TM today announced ... , a commercial and financial hub from which many biotech ... testing laboratories in mainland China . ... Bioscience,s global sales with almost sixty MassARRAY ® Systems ... will allow us to expand our reach and foster ...
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... 2,500 employees, SHL Group has rapidly reached 3,000 ... yet rapid growth in the injectable drug delivery ... A global leader in the design ... SHL offers innovative designs, robust manufacturing capabilities, a ...
(Date:9/1/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rd9jbr/introduction_to ... "Introduction to Veterinary Pharmacovigilance (London, UK - September ... This course has been designed to provide ... concerned with Veterinary Pharmacovigilance. New entrants, support staff ... better understanding of veterinay drug safety will benefit ...
Breaking Medicine Technology:Agena Bioscience Opens Office in Shanghai, China 2SHL Group Reaches Major Milestone of 3000 Employees 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
(Date:9/1/2015)... ... ... With former IBMers among its founding members, Inmar has known the value ... years ago. A pilot program begun by the company in 2014 has proved popular ... on pursuing careers in these fields. The program is now open to area middle ...
(Date:9/1/2015)... York (PRWEB) , ... September 01, 2015 , ... Zecurion, ... Zlock Mac , its groundbreaking new version of endpoint DLP developed specifically for Mac ... Mac, in which more than 100 IT and information security professionals had participated. The ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, local food access, and ... be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference : “Innovation and the ... , In addition to keynotes Pierre Sleiman, founder and CEO of Go Green Agriculture, ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine (IOM) of ... of Biomedical Informatics at Columbia University School of Nursing. A member of the ...
(Date:9/1/2015)... ... 01, 2015 , ... The PracticeMatch Career Fair ... the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, IN 46225. More than ... the country. All specialties will be represented. Attendees will enjoy free hors d’oeuvres ...
Breaking Medicine News(10 mins):Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4
... Quarter Revenue up 29% to $50.4 Million Strong ... Full Year Revenue Growth of 17% to ... Feb. 28 Cardiac Science,Corporation (Nasdaq: CSCX ), ... informatics products, today announced,record results for the fourth quarter ...
... Robert Leonard, Founder and,Chief Surgeon of Leonard Hair Transplant ... the availability of a new genetic test for male,pattern ... New England to,offer this to patients., Dr. Robert ... be,affected by genetic male pattern baldness. This exciting new ...
... of the patent office "non-final" decision on a human ... Foundation (WARF),shows the following gains made for researchers:, ... was underserved,and new amended claims have been narrowed., ... no matter how,they are derived, but the amended "non-final" ...
... of two cellular receptors that likely contribute to the genesis ... targeted therapies against the disease, says a team led by ... , The finding also helps explain how daily use of ... at bay. , "These two receptors, called EP2 and EP4, ...
... Their U.S. Representative if they Support,Administration,s Medicare Cuts, ... to,begin debate on the Bush Administration,s proposed FY ... nursing home benefit,a new national survey conducted by ... finds 63 percent of likely voters oppose the,cut ...
... Missouri scientist Kattesh Katti recently discovered how to ... water. Kattis research has garnered attention worldwide and ... several disciplines. , Gold nanoparticles are tiny pieces ... by the naked eye. Researchers believe gold nanoparticles ...
Cached Medicine News:Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 2Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 3Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 4Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 5Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 6Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 7Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 8Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 9Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 10Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 11Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 12Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 14Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 15Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 16Health News:Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 17Health News:Dr. Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness 2Health News:Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims 2Health News:Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer 2Health News:Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer 3Health News:New National Poll: Majority of American Voters Oppose Bush Administration's Proposed Cuts to Medicare 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 3
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
These backbiters enable simple access to the anterior horn of the meniscus....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
Medicine Products: